These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34460879)

  • 41. [Impact of duration of untreated psychosis on quality of life and cognitive functions].
    Rebhi H; Damak R; Cherif W; Ellini S; Cheour M; Ellouze F
    Encephale; 2019 Feb; 45(1):22-26. PubMed ID: 29499848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: severe negative syndrome may be related to a distinct lipid pathophysiology.
    Chen SF; Hu TM; Lan TH; Chiu HJ; Sheen LY; Loh EW
    Eur Psychiatry; 2014 Mar; 29(3):167-71. PubMed ID: 23769679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
    Zhang Y; Dai G
    Hum Psychopharmacol; 2012 Nov; 27(6):605-14. PubMed ID: 24446539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
    González-Valderrama A; Castañeda CP; Mena C; Undurraga J; Mondaca P; Yañez M; Bedregal P; Nachar R
    Early Interv Psychiatry; 2017 Feb; 11(1):77-82. PubMed ID: 26256570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients.
    Wójciak P; Domowicz K; Rybakowski JK
    World J Biol Psychiatry; 2021 Sep; 22(7):552-556. PubMed ID: 33176545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls.
    Yang Z; Zhu Y; Song Z; Mei L; Zhang J; Chen T; Wang Y; Xu Y; Jiang K; Li Y; Liu D
    Shanghai Arch Psychiatry; 2015 Dec; 27(6):341-7. PubMed ID: 27199525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Similarities and Differences in Associations Between Duration of Untreated Psychosis (DUP) and Demographic, Premorbid, and Symptom Severity Measures in Two Samples of First-Episode Psychosis Patients from Mexico and the United States.
    Fresan A; Apiquian R; Robles-García R; Zarate CT; Balducci PM; Broussard B; Wan CR; Compton MT
    Psychiatr Q; 2020 Sep; 91(3):769-781. PubMed ID: 32221766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of metabolic parameters, neurotrophin-3, and neurotrophin-4 serum levels in women with schizophrenia and first-onset depression.
    Skibinska M; Kapelski P; Rajewska-Rager A; Szczepankiewicz A; Narozna B; Duda J; Dmitrzak-Weglarz M; Twarowska-Hauser J; Pawlak J
    Nord J Psychiatry; 2019 Feb; 73(2):96-103. PubMed ID: 30654674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tunisian mothers' beliefs about their child's first psychotic episode].
    Bourgou S; Halayem S; Bouden A; Halayem MB
    Encephale; 2012 Dec; 38(6):473-9. PubMed ID: 23200613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
    Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Decara MS; Fagerlund B; Jepsen JRM; Eriksson F; Fink-Jensen A; Pagsberg AK
    J Am Acad Child Adolesc Psychiatry; 2019 Nov; 58(11):1062-1078. PubMed ID: 30858012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between referral source and duration of untreated psychosis in pathways to care among first episode psychosis patients in Northern Malawi.
    Kaminga AC; Myaba J; Dai W; Liu A; Chilale HK; Kubwalo PF; Madula P; Banda R; Pan X; Wen SW
    Early Interv Psychiatry; 2020 Oct; 14(5):594-605. PubMed ID: 31657157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia.
    Barnes TR; Leeson VC; Mutsatsa SH; Watt HC; Hutton SB; Joyce EM
    Br J Psychiatry; 2008 Sep; 193(3):203-9. PubMed ID: 18757977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do clinical characteristics predict the cognitive course in early-onset schizophrenia-spectrum disorders?
    Teigset CM; Mohn C; Brunborg C; Juuhl-Langseth M; Holmén A; Rund BR
    J Child Psychol Psychiatry; 2018 Sep; 59(9):1012-1023. PubMed ID: 29573345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample.
    Cuesta MJ; Peralta V; Campos MS; Garcia-Jalon E
    Schizophr Res; 2011 Aug; 130(1-3):148-56. PubMed ID: 21632216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of untreated psychosis and clinical outcomes of first-episode schizophrenia: a 4-year follow-up study.
    Qin H; Zhang J; Wang Z; Min H; Yan C; Chen F; Fu W; Zhang M
    Shanghai Arch Psychiatry; 2014 Feb; 26(1):42-8. PubMed ID: 25114480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis.
    Mueser KT; DeTore NR; Kredlow MA; Bourgeois ML; Penn DL; Hintz K
    Acta Psychiatr Scand; 2020 Feb; 141(2):157-166. PubMed ID: 31557309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long term functioning in early onset psychosis: two years prospective follow-up study.
    Hassan GA; Taha GR
    Behav Brain Funct; 2011 Jul; 7():28. PubMed ID: 21801438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.